- Home
- PODD
PODD
Insulet Corporation
as 11-15-2024 4:00pm EST
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | ACTON |
| Market Cap: | 16.5B | IPO Year: | 2007 |
| Target Price: | $251.53 | AVG Volume (30 days): | 609.1K |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 5.74 | EPS Growth: | 235.68 |
| 52 Week Low/High: | $160.19 - $279.40 | Next Earning Date: | 11-07-2024 |
| Revenue: | $1,983,900,000 | Revenue Growth: | 27.42% |
| Revenue Growth (this year): | 22.33% | Revenue Growth (next year): | 18.50% |
Stock Insider Trading Activity of Insulet Corporation (PODD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Hopfield Jessica | PODD | Director | Sep 11 '24 | Sell | $225.26 | 7,628 | $1,718,283.28 | 26,917 | |
| Scannell Timothy J | PODD | Director | Sep 10 '24 | Sell | $225.84 | 5,000 | $1,129,200.00 | 30,586 | |
| Field Mark N | PODD | SVP & Chief Technology Officer | Sep 9 '24 | Sell | $220.87 | 1,383 | $305,463.21 | 9,761 | |
| Budden Lauren | PODD | Group VP, CAO and Controller | Sep 9 '24 | Sell | $221.41 | 1,506 | $333,443.46 | 6,609 | |
| Singh Prem | PODD | SVP, Global Operations | Aug 30 '24 | Sell | $202.27 | 1,824 | $368,940.48 | 3,656 | |
| Chadwick Ana Maria | PODD | EVP, CFO & Treasurer | Aug 29 '24 | Buy | $206.00 | 100 | $20,600.00 | 13,314 |
Latest Insulet Corporation News
PODD Breaking Stock News: Dive into PODD Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals
Business Wire
2 days ago
Insulet to Present at Upcoming Investor Conferences
Zacks
4 days ago
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks
4 days ago
Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace
Argus Research
5 days ago
PODD: Raising target price to $289.00
Zacks
5 days ago
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More
Zacks
5 days ago
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Zacks
5 days ago
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up
Compare PODD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PODD Insulet Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.